Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 27 October 2022, 18:04 HKT/SGT
Share:
    

Source: Eminence Business Media
Watch the Biggest T10 Indian Pharma Championship on VOOT live

MUMBAI, INDIA, Oct 27, 2022 - (ACN Newswire) - Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10 Indian Pharma Champions Trophy 2022 scheduled for December 1-7, 2022, in Mumbai. Managing Director of Eminence Business Media, Ms. Guneet Kaur Hayer, believes that cricket is not just a sport for many; it is an emotion and as a company they want people to take a short rejuvenating break from their tiring work, and to do something that works for their physical health, mental health, and fitness at par. She also said it is every company's responsibility to keep their employees healthy, fit, engaged, appreciated and happy with their jobs.


For the first time ever, a cricket league of such a high stature has been announce exclusively for the Pharmaceutical Industry that would make an enduring impact on people's lives. It provides great entertainment, teaches important skills; physical, mental, and social.

What's in It for the Pharma Teams?
1. Winning prize money for up to INR 25 Lakhs.
2. Live streaming gives that celebrity vibe to show your talent on the screen to 20 million viewers.
3. Four-wheeler, two wheelers and several other remunerative awards for Man of the Series, Man of the Matches, Purple Hat, Orange Hat Winners and more.
4. Win gadgets like Laptops, mobiles and more.
5. Best of all is the joy of playing cricket and winning the championship.
6. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

What's in It for the Sponsors?
1. Exclusive Brand Positioning & Visibility.
2. Exclusive marketing
3. Live streaming on VOOT across the nation.
4. On air campaigns in multiple cities.
5. Network and enhance your market reach.
6. Pre- scheduled meetings.
7. Support NGO by participating, or partnering, where in part percentage will go in donation to them.


Topic: Press release summary
Source: Eminence Business Media


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
GMG Board Approves Capital for Engineering of Factory for Graphene Factories  
July 8, 2026 19:59 HKT/SGT
Atha Energy Makes Major New High-Grade Discovery along the Lac 50 Corridor - Intersects 11.5 m of Composite Uranium Mineralization Including 1.6 m of Near Continuous High-Grade 4 km Along Strike from Lac 50 Deposit Area  
July 8, 2026 19:00 HKT/SGT
Phoenitron Enters Intelligent Fire Protection Sector via CyberMirage's Strategic Cooperation Framework Agreement  
July 8, 2026 18:05 HKT/SGT
The 3rd ASEAN Operational Excellence & Business Transformation Summit 2026 to Bring Together ASEAN's Leading Transformation and Operations Executives in Kuala Lumpur  
July 8, 2026 18:05 HKT/SGT
China-France Cultural Dialogue Highlights Research on the Overseas Dissemination of Xi Jinping: The Governance of China V  
July 8, 2026 17:00 HKT/SGT
Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib  
July 8, 2026 12:30 HKT/SGT
SIMCo Expands Infrastructure Debt Franchise through Strategic Partnerships with PIMCO and Investec  
July 8, 2026 11:11 HKT/SGT
Eromnet Obtains Singapore MPI License, Expanding Global Fintech Business  
July 8, 2026 10:25 HKT/SGT
GMG Reports Record Sales Orders for June 2026 of over A$400k  
July 7, 2026 22:21 HKT/SGT
Radisson Reports Highest-Ever Assay Result at O'Brien: 1,604 g/t (1.60 kg/t) Gold over 1.0 Metre Within 316 g/t Gold over 5.1 Metres  
July 7, 2026 21:56 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: